For the quarter ending 2025-09-30, HCAT made $76,323K in revenue. -$22,229K in net income. Net profit margin of -29.12%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total revenue | 76,323 | 80,721 | 76,353 | 75,902 |
| Technology | 17,203 | 18,352 | - | - |
| Professional Services | 21,304 | 24,128 | - | - |
| Total cost of revenue, excluding depreciation and amortization | 38,507 | 42,480 | 42,313 | 40,060 |
| Sales and marketing | 14,361 | 13,206 | 11,342 | 12,745 |
| Research and development | 12,281 | 12,392 | 14,193 | 13,884 |
| General and administrative | 16,069 | 8,284 | 12,209 | 14,363 |
| Depreciation and amortization | 12,614 | 12,684 | 9,983 | 10,657 |
| Goodwill impairment | 0 | 28,769 | - | - |
| Total operating expenses | 55,325 | 75,335 | 47,727 | 51,649 |
| Loss from operations | -17,509 | -37,094 | -13,687 | -15,807 |
| Interest and other income, net | - | - | - | 2,361 |
| Interest and other (expense) income, net | -4,679 | -3,803 | -1,514 | - |
| Loss before income taxes | -22,188 | -40,897 | -15,201 | -13,446 |
| Income tax provision (benefit) | 41 | 81 | -475 | 70 |
| Net loss | -22,229 | -40,978 | -14,726 | -13,516 |
| Net loss per share, basic (in usd per share) | -0.32 | -0.59 | -0.24 | -0.23 |
| Net loss per share, diluted (in usd per share) | -0.32 | -0.59 | -0.24 | -0.23 |
| Weighted-average shares outstanding used in calculating net loss per share, basic (in shares) | 70,377,000 | 69,626,000 | 60,441,000 | 59,304,000 |
| Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares) | 70,377,000 | 69,626,000 | 60,441,000 | 59,304,000 |
Health Catalyst, Inc. (HCAT)
Health Catalyst, Inc. (HCAT)